patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: I pretty much gave up hopes on this company....

Yup think i ended up with 13 or so from the r/s - bought lil down at .5 after rs n it got slammed, but got most at 1.15 n 1.50 or so.

Commercialization next imvho -

If we get decent results on MS trials loookout -

e

Share
New Message
Please login to post a reply